PPAR alpha regulation of the immune response and autoimmune encephalomyelitis

PPAR Research

Volumn , Issue , 2008, Pages

  Yang, Yuhong ^a   Gocke, Anne R ^b   Lovett Racke, Amy ^a   Drew, Paul D ^c   Racke, Michael K ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 17; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; RETINOID X RECEPTOR; TRANSCRIPTION FACTOR;

ALLERGIC ENCEPHALOMYELITIS; B LYMPHOCYTE; CELL DIFFERENTIATION; CYTOKINE PRODUCTION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HORMONAL REGULATION; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; INFLAMMATION; LANGERHANS CELL; MACROPHAGE; MONOCYTE; MULTIPLE SCLEROSIS; NONHUMAN; PROTEIN EXPRESSION; RECEPTOR BINDING; REVIEW; T LYMPHOCYTE; TRANSACTIVATION;

EID: 48749132127     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/2008/546753     Document Type: Review

References (38)

1. Desvergne B., Wahli W., Peroxisome proliferator-activated receptors: nuclear control of metabolism Endocrine Reviews 1999 20 5 649 688
2. Mangelsdorf D. J., Thummel C., Beato M., The nuclear receptor super-family: the second decade Cell 1995 83 6 835 839
3. Braissant O., Foufelle F., Scotto C., Dauça M., Wahli W., Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-α,-β, and-γ in the adult rat Endocrinology 1996 137 1 354 366
4. Kliewer S. A., Forman B. M., Blumberg B., Differential expression and activation of a family of murine peroxisome proliferator-activated receptors Proceedings of the National Academy of Sciences of the United States of America 1994 91 15 7355 7359
5. Anderson D. W., Ellenberg J. H., Leventhal C. M., Reingold S. C., Rodriguez M., Silberberg D. H., Revised estimate of the prevalence of multiple sclerosis in the United States Annals of Neurology 1992 31 3 333 336
6. Sadovnick A. D., Ebers G. C., Epidemiology of multiple sclerosis: a critical overview Canadian Journal of Neurological Sciences 1993 20 1 17 29
7. The IFNB Multiple Sclerosis Study Group, Interferon beta-1b is effective in relapsing-remitting multiple sclerosis-I: clinical results of a multicenter, randomized, double-blind, placebo-controlled trial Neurology 1993 43 4 655 661
8. Jacobs L. D., Cookfair D. L., Rudick R. A., Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis Annals of Neurology 1996 39 3 285 294
9. Johnson K. P., Brooks B. R., Cohen J. A., Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind, placebo-controlled trial Neurology 1995 45 7 1268 1276
10. Millefiorini E., Gasperini C., Pozzilli C., Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcome Journal of Neurology 1997 244 3 153 159
11. Kleinschmidt-DeMasters B. K., Tyler K. L., Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis The New England Journal of Medicine 2005 353 4 369 374
12. Langer-Gould A., Atlas S. W., Green A. J., Bollen A. W., Pelletier D., Progressive multifocal leukoencephalopathy in a patient treated with natalizumab The New England Journal of Medicine 2005 353 4 375 381
13. Van Assche G., Van Ranst M., Sciot R., Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease The New England Journal of Medicine 2005 353 4 362 368
14. Miller S. D., Karpus W. J., The immunopathogenesis and regulation of T-cell-mediated demyelinating diseases Immunology Today 1994 15 8 356 361
15. Chinetti G., Griglio S., Antonucci M., Activation of proliferator- activated receptorsα and γ induces apoptosis of human monocyte-derived macrophages The Journal of Biological Chemistry 1998 273 40 25573 25580
16. Jones D. C., Ding X., Daynes R. A., Nuclear receptor peroxisome proliferator-activated receptorα (PPARα) is expressed in resting murine lymphocytes. The PPARα in T and B lymphocytes is both transactivation and transrepression competent The Journal of Biological Chemistry 2002 277 9 6838 6845
17. Cunard R., Ricote M., DiCampli D., Regulation of cytokine expression by ligands of peroxisome proliferator activated receptors Journal of Immunology 2002 168 6 2795 2802
18. Dubrac S., Stoitzner P., Pirkebner D., Peroxisome proliferator-activated receptor-α activation inhibits Langerhans cell function Journal of Immunology 2007 178 7 4362 4372
19. Devchand P. R., Keller H., Peters J. M., Vazquez M., Gonzalez F. J., Wahli W., The PPARα -leukotriene B 4 pathway to inflammation control Nature 1996 384 6604 39 43
20. Delerive P., De Bosscher K., Besnard S., Peroxisome proliferator- activated receptorα negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF- κ B and AP-1 The Journal of Biological Chemistry 1999 274 45 32048 32054
21. Cunard R., DiCampli D., Archer D. C., WY14,643, a PPARα ligand, has profound effects on immune responses in vivo Journal of Immunology 2002 169 12 6806 6812
22. Lee J. W., Bajwa P. J., Carson M. J., Fenofibrate represses interleukin-17 and interferon- γ expression and improves colitis in interleukin-10-deficient mice Gastroenterology 2007 133 1 108 123
23. Jones D. C., Ding X., Zhang T. Y., Daynes R. A., Peroxisome proliferator-activated receptorα negatively regulates T-bet transcription through suppression of p38 mitogen-activated protein kinase activation Journal of Immunology 2003 171 1 196 203
24. Dasgupta S., Roy A., Jana M., Hartley D. M., Pahan K., Gemfibrozil ameliorates relapsing-remitting experimental autoimmune encephalomyelitis independent of peroxisome proliferator-activated receptor-α Molecular Pharmacology 2007 72 4 934 946
25. Sumanasekera W. K., Tien E. S., Turpey R., Vanden Heuvel J. P., Perdew G. H., Evidence that peroxisome proliferator-activated receptorα is complexed with the 90-kDa heat shock protein and the hepatitis virus B X-associated protein 2 The Journal of Biological Chemistry 2003 278 7 4467 4473
26. Sumanasekera W. K., Tien E. S., Davis J. W. II, Turpey R., Perdew G. H., Vanden Heuvel J. P., Heat shock protein-90 (Hsp90) acts as a repressor of peroxisome proliferator-activated receptor-α (PPARα) and PPAR β activity Biochemistry 2003 42 36 10726 10735
27. Gocke A., Hussain R., Ben L., Drew P. D., Lovett-Racke A. E., Racke M. K., Transcriptional modulation of the immune response by peroxisomal proliferator-activated receptor-α agonists in autoimmune disease. submitted
28. Pascual G., Fong A. L., Ogawa S., A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR- γ Nature 2005 437 7059 759 763
29. Spencer N. F. L., Poynter M. E., Im S.-Y., Daynes R. A., Constitutive activation of NF- κ B in an animal model of aging International Immunology 1997 9 10 1581 1588
30. Delerive P., Gervois P., Fruchart J.-C., Staels B., Induction of I κ Bα expression as a mechanism contributing to the anti-inflammatory activities of peroxisome proliferator-activated receptor-α activators The Journal of Biological Chemistry 2000 275 47 36703 36707
31. Delerive P., De Bosscher K., Berghe W. V., Fruchart J.-C., Haegeman G., Staels B., DNA binding-independent induction of I κ Bα gene transcription by PPARα Molecular Endocrinology 2002 16 5 1029 1039
32. Lee J. H., Joe E. H., Jou I., PPAR-alpha activators suppress STAT1 inflammatory signaling in lipopolysaccharide-activated rat glia NeuroReport 2005 16 8 829 833
33. Selim E., Frkanec J. T., Cunard R., Fibrates upregulate TRB3 in lymphocytes independent of PPARα by augmenting CCAAT/enhancer-binding protein β (C/EBP β) expression Molecular Immunology 2007 44 6 1218 1229
34. Lovett-Racke A. E., Hussain R. Z., Northrop S., Peroxisome proliferator-activated receptorα agonists as therapy for autoimmune disease Journal of Immunology 2004 172 9 5790 5798
35. Dunn S. E., Ousman S. S., Sobel R. A., Peroxisome proliferator-activated receptor (PPAR)α expression in T cells mediates gender differences in development of T cell-mediated autoimmunity Journal of Experimental Medicine 2007 204 2 321 330
36. Xu J., Storer P. D., Chavis J. A., Racke M. K., Drew P. D., Agonists for the peroxisome proliferator-activated receptor-α and the retinoid X receptor inhibit inflammatory responses of microglia Journal of Neuroscience Research 2005 81 3 403 411
37. Xu J., Chavis J. A., Racke M. K., Drew P. D., Peroxisome proliferator-activated receptor-α and retinoid X receptor agonists inhibit inflammatory responses of astrocytes Journal of Neuroimmunology 2006 176 1-2 95 105
38. Xu J., Racke M. K., Drew P. D., Peroxisome proliferator-activated receptor-α agonist fenofibrate regulates IL-12 family cytokine expression in the CNS: relevance to multiple sclerosis Journal of Neurochemistry 2007 103 5 1801 1810